Madeed Raises $925K Pre‑seed to Scale Personalised Preventive Healthcare in Saudi Arabia

Why It Matters

The infusion of capital accelerates Madeed’s ability to commercialize a data‑driven preventive health model, a segment poised for rapid growth in the Gulf’s expanding digital‑health market. It also signals strong investor confidence in AI‑enabled, personalized healthcare solutions in the region.

Key Takeaways

• Total pre‑seed funding now $925K
• AI‑driven biomarkers target early disease detection
• 150 pilot subscribers indicate market demand
• Partnerships with labs and clinics to start in Saudi
• Investors include SEEDRA, Unity and Seen Growth

Pulse Analysis

Saudi Arabia is rapidly positioning itself as a hub for digital health innovation, driven by government initiatives such as Vision 2030 that prioritize preventive care and technology adoption. In this environment, Madeed’s focus on early disease risk detection aligns with a broader regional shift from reactive treatment to proactive health management. By leveraging sophisticated biomarker panels and artificial intelligence, the startup aims to fill a gap in the market where personalized, data‑rich health insights remain scarce, especially for chronic disease prevention.

Madeed’s platform distinguishes itself by integrating laboratory data with AI algorithms to generate individualized health scores and actionable recommendations. During its pilot phase, the company attracted 150 subscribers, a strong early validation of consumer appetite for tailored preventive services. The additional $525,000 pre‑seed injection will enable the firm to refine its product suite, scale its laboratory network, and deepen clinical partnerships, laying the groundwork for a broader rollout across Saudi Arabia’s private and public health sectors.

The funding round underscores growing investor confidence in health‑tech ventures that combine AI, genomics, and preventive care. SEEDRA Ventures, Unity Investment Partners, and Seen Growth bring not only capital but also strategic expertise that can help Madeed navigate regulatory pathways and expand regionally. As the Middle East’s first dedicated preventive health platform, Madeed could set a precedent for similar models across the GCC, potentially attracting further venture capital and accelerating the region’s transition toward data‑driven, longevity‑focused healthcare.

Deal Summary

Saudi healthtech startup Madeed announced the closing of a $925,000 pre‑seed round, bringing its total funding to $925,000. The round was led by SEEDRA Ventures, Unity Investment Partners and Seen Growth, with participation from earlier investor Vision Ventures. The capital will be used to develop its AI‑driven preventive health platform and expand clinical and lab partnerships in Saudi Arabia.